about
Trial Watch:: Oncolytic viruses for cancer therapyFirst oncolytic virus approved for melanoma immunotherapy.Chimeric antigen receptor-engineered T cells as oncolytic virus carriers.Evolving role of tumor antigens for future melanoma therapies.Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?Oncolytic Immunotherapy for Treatment of Cancer.What have we learned from cancer immunotherapy in the last 3 years?Gene therapy in the clinics: shifting into the next gear.Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-radiation and small molecule inhibitors of cell signaling pathways.
P2860
Q27021951-2BCA862B-4A1A-4E88-82D2-27605A297013Q36597333-8275B340-5DE5-42B4-8AEC-75D2F681D9ECQ36664258-C71FC5AF-EFDF-4375-8114-8A7DFD172998Q38232855-2F18DBC8-6A48-4D92-A249-9565A8CDA80EQ38348844-796FE2AE-954B-4719-BB94-2F1E63BC4458Q38848223-3940B5A2-F679-4A73-B2F1-1D9CCBA96C80Q40065733-0D18EA06-E950-4434-8787-EF7E80F08ACBQ44676658-3ED0F3A3-E6D8-4510-9476-6DCF95EE81C3Q45410310-03114DFE-6DEB-452F-8310-0E78A53675EB
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Cancer immunotherapy turns viral
@en
type
label
Cancer immunotherapy turns viral
@en
prefLabel
Cancer immunotherapy turns viral
@en
P2860
P356
P1433
P1476
Cancer immunotherapy turns viral
@en
P2093
Enrico Lugli
P2860
P304
P356
10.4161/ONCI.24802
P577
2013-04-01T00:00:00Z